In a study published in Nature, researchers used intercellular CRISPR screening to identify PRFs in cancer cells, and using genome-wide reverse screening in macrophages, they found that the G-protein-coupled receptor GPR84 mediates enhanced phagocytosis in APMAP-deficient cancer cells. The gene discussed is APMAP; the disease is cancer.